Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.39 |
| ▸ | LMNA | P02545 | 4/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | PTGES | O14684 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | PPARA | Q07869 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12619718 | 0.95 | CYP3A4 (0.42) | TDP1ALDH1A1CYP3A4LMNAHSD17B10 | |
| SCHEMBL10057744 | 0.95 | TDP1 (0.47) | TDP1ALDH1A1CYP3A4LMNAHSD17B10 | |
| SCHEMBL8943702 | 0.91 | TDP1 (0.50) | TDP1ALDH1A1CYP3A4LMNAHSD17B10 | |
| SCHEMBL13581607 | 0.88 | CYP3A4 (0.43) | TDP1ALDH1A1CYP3A4LMNAHSD17B10 | |
| SCHEMBL16500695 | 0.85 | TDP1 (0.34) | TDP1ALDH1A1CYP3A4LMNAHSD17B10 | |
| SCHEMBL10025036 | 0.85 | TDP1 (0.34) | TDP1ALDH1A1CYP3A4LMNAHSD17B10 | |
| SCHEMBL762244 | 0.84 | CYP3A4 (0.45) | TDP1ALDH1A1CYP3A4LMNAHSD17B10 | |
| SCHEMBL1822785 | 0.84 | TDP1 (0.56) | TDP1ALDH1A1CYP3A4LMNAHSD17B10 | |
| SCHEMBL20357876 | 0.83 | CYP3A4 (0.47) | TDP1ALDH1A1CYP3A4LMNAHSD17B10 | |
| SCHEMBL8943687 | 0.82 | CYP3A4 (0.46) | TDP1ALDH1A1CYP3A4LMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170082426-A1 | DETECTOR FOR OPTICALLY DETECTING AT LEAST ONE OBJECT | BASF SE (DE) | 2017-03-23 | — | — | US | disclosed |
| US-9595678-B2 | Dye solar cell with improved stability | BASF SE (DE) | 2017-03-14 | — | — | US | disclosed |
| US-9087991-B2 | Photovoltaic element | BASF SE (DE) | 2015-07-21 | — | — | US | disclosed |
| US-20150124268-A1 | DETECTOR FOR OPTICALLY DETECTING AT LEAST ONE OBJECT | BASF SE (DE) | 2015-05-07 | — | — | US | disclosed |
| US-9001029-B2 | Detector for optically detecting at least one object | BASF SE (DE) | 2015-04-07 | — | — | US | disclosed |
| US-20140130870-A1 | USE OF TRIARYLAMINE DERIVATIVES AS HOLE-CONDUCTING MATERIALS IN ORGANIC SOLAR CELLS AND ORGANIC SOLAR CELLS CONTAINING SAID TRIARYLAMINE DERIVATIVES | BASF SE (DE) | 2014-05-15 | — | — | US | disclosed |
| US-20120279566-A1 | PHOTOVOLTAIC ELEMENT WITH INCREASED LONG-TERM STABILITY | BASF SE (DE) | 2012-11-08 | — | — | US | disclosed |
| US-20120206336-A1 | DETECTOR FOR OPTICALLY DETECTING AT LEAST ONE OBJECT | BASF SE (DE) | 2012-08-16 | — | — | US | disclosed |
| US-20120192945-A1 | PHOTOVOLTAIC ELEMENT | BASF SE (DE) | 2012-08-02 | — | — | US | disclosed |
| US-20120017995-A1 | DYE SOLAR CELL WITH IMPROVED STABILITY | BASF SE (DE) | 2012-01-26 | — | — | US | disclosed |
| US-20110297235-A1 | USE OF TRIARYLAMINE DERIVATIVES AS HOLE-CONDUCTING MATERIALS IN ORGANIC SOLAR CELLS AND ORGANIC SOLAR CELLS CONTAINING SAID TRIARYLAMINE DERIVATIVES | BASF SE (DE) | 2011-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110297235-A1 | USE OF TRIARYLAMINE DERIVATIVES AS HOLE-CONDUCTING MATERIALS IN ORGANIC SOLAR CELLS AND ORGANIC SOLAR CELLS CONTAINING SAID TRIARYLAMINE DERIVATIVES | NR2E3, NR0B2, AHR | TDP1 2814/4885ALDH1A1 1407/4885CYP3A4 703/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.